Skip to main content

Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.

Yun BH, Rosenquist TA, Nikolić J, Dragičević D, Tomić K, Jelaković B, Dickman KG, Grollman AP, Turesky RJ

Publication: Anal Chem (2013) • Vol 85 • Page 4251-8PMID: 23550627View on PubMed

Purpose

The purpose of this paper was to determine the effects of preservation method and detection method on quantification of deoxyadenosine (dA)-aristolactam (AL-I) adducts in upper urinary tract cancer specimens.

Conclusion

When analyzed by liquid chromatography mass-spectrometry (LC-MS), frozen and FFPE specimens had comparable levels of dA-AL-I adducts. For frozen specimens (FFPE was not investigated), the quantification of dA-AL-I adducts by LC-MS was comparable to that quantified by radioassay, but LC-MS was more sensitive.

Studies (1)

Purpose

The purpose of this study was to determine the effects of preservation method and detection method on quantification of dA-AL-I adducts in upper urinary tract cancer specimens. 5 specimens were immediately frozen at -80°C or fixed for 24 h in formalin. FFPE blocks were stored at room temperature. DNA was extracted from frozen specimens using a phenol-chloroform based method and from FFPE specimens using a modification of the ZR FFPE DNA MiniPrep kit.

Summary of Findings

dA-AL-I adduct levels measured by LC-MS were comparable in frozen (0.13-7.0) and FFPE specimens (0.48-6.2). For frozen specimens (FFPE was not investigated), the levels of dA-AL-I adducts measured by LC-MS were comparable to those measured by radioassay, but LC-MS was more sensitive.

  • Biospecimens

    TissueKidney
  • Preservation Types

    FrozenFormalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNALC-ESI-MS/MS
    DNARadioassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Frozen
    LC-ESI-MS/MS SpecificTechnology platform
    Radioassay